Hutch News

Researchers identify strong T-cell response in first-in-human nanoparticle HIV vaccine

Researchers identify strong T-cell response in first-in-human nanoparticle HIV vaccine

Study result moves scientists closer to developing elusive HIV vaccine
News Releases - May 24, 2023

New Science Spotlight Articles

Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
13 NEW May 24, 2023
Does HIV disease progression differ by ancestry?

Does HIV disease progression differ by ancestry?

From Drs. Shuying (Sue) Li and Peter Gilbert, Vaccine and Infectious Disease Division
Science Spotlight - September 19, 2022
License to Kill: Latency HIV-CRISPR pinpoints how to blow latent HIV’s cover

License to Kill: Latency HIV-CRISPR pinpoints how to blow latent HIV’s cover

From the Emerman and Henikoff Labs, Pathogen Associated Malignancies and Cancer Basic Biology Programs, Cancer Consortium.
Science Spotlight - September 19, 2022
HIV antibody trial results offer 'proof of concept'

HIV antibody trial results offer 'proof of concept'

Outcome of AMP shows feasibility of developing potent antibody combinations to block HIV
Hutch News - March 17, 2021
No ‘black diamond’ ski slopes for the TRIM5α antiviral protein

No ‘black diamond’ ski slopes for the TRIM5α antiviral protein

From the Malik and Emerman labs, Basic Sciences Division
Science Spotlight - October 19, 2020